Search research articles
Contact Us
Filters
Showing results (241-250 of 397) with videos related to
Page
of 40
Sort By:
Molecular Cancer Therapeutics
|
September 26, 2014
Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents
Prasanth Ganesan, Stacy Moulder, J Jack Lee, et al.
Cancer
|
July 15, 2016
Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials
Goldy C George, Eucharia C Iwuanyanwu, Karen O Anderson, et al.
Journal of Hematology
|
July 15, 2022
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience
Blessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2019
Corrigendum to "Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials" [Lung Cancer 120 (June) (2018) 137-141]
Hossein Maymani, Kenneth Hess, Roman Groisberg, et al.
Oncotarget
|
May 6, 2016
Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience
Ming-Mo Hou, Zhijie Wang, Filip Janku, et al.
Cancer Chemotherapy and Pharmacology
|
March 26, 2016
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
Muhammad R Khawaja, Alpa M Nick, Vinu Madhusudanannair, et al.
Clinical Epigenetics
|
March 26, 2015
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
Apostolia M Tsimberidou, Rabih Said, Kirk Culotta, et al.
Journal of Infection in Developing Countries
|
September 13, 2021
Community responses to COVID-19 pandemic first wave containment measures: a multinational study
Myo Nyein Aung, Claire Stein, Wei-Ti Chen, et al.
Oncotarget
|
December 19, 2012
PIK3CA mutations in advanced cancers: characteristics and outcomes
Filip Janku, Jennifer J Wheler, Aung Naing, et al.
Page
of 40
Search research articles
Search
Showing results (241-250 of 397) with videos related to
Sort By:
Page
of 40
Molecular Cancer Therapeutics
|
September 26, 2014
Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents
Prasanth Ganesan, Stacy Moulder, J Jack Lee, et al.
Cancer
|
July 15, 2016
Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials
Goldy C George, Eucharia C Iwuanyanwu, Karen O Anderson, et al.
Journal of Hematology
|
July 15, 2022
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience
Blessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, et al.
The Oncologist
|
March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies
Jibran Ahmed, Anne Knisely, Carlos Torrado, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2019
Corrigendum to "Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials" [Lung Cancer 120 (June) (2018) 137-141]
Hossein Maymani, Kenneth Hess, Roman Groisberg, et al.
Oncotarget
|
May 6, 2016
Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience
Ming-Mo Hou, Zhijie Wang, Filip Janku, et al.
Cancer Chemotherapy and Pharmacology
|
March 26, 2016
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
Muhammad R Khawaja, Alpa M Nick, Vinu Madhusudanannair, et al.
Clinical Epigenetics
|
March 26, 2015
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
Apostolia M Tsimberidou, Rabih Said, Kirk Culotta, et al.
Journal of Infection in Developing Countries
|
September 13, 2021
Community responses to COVID-19 pandemic first wave containment measures: a multinational study
Myo Nyein Aung, Claire Stein, Wei-Ti Chen, et al.
Oncotarget
|
December 19, 2012
PIK3CA mutations in advanced cancers: characteristics and outcomes
Filip Janku, Jennifer J Wheler, Aung Naing, et al.
Page
of 40